Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ravenquest Biomed Inc RVVQF

Ravenquest BioMed Inc is a Canada-based diversified cannabis company with divisions focused upon cannabis production, management services and consulting and specialized research and development. It provides integrated solutions to companies in the cannabis industry and provides growing and drying technologies, patient and genetic management systems, and security management solutions The company operates through the following segments - Consulting business and Cultivation and Sale of Medical Cannabis.


GREY:RVVQF - Post by User

Post by ourrugon Jul 09, 2019 1:33pm
111 Views
Post# 29899912

George Robinson Quoted on BNN Bloomberg

George Robinson Quoted on BNN Bloomberg
While the company [CannTrust] said the financial impact from its non-compliance is unknown, the value of the 12,700 kilograms of unsold cannabis on the wholesale market is pegged to be close to $70 million, according to George Robinson, chief executive officer of RavenQuest Biomed Inc.
 
Robinson, who also took over CEO duties at Bonify Inc. after Health Canada found the Winnipeg-based cannabis producer sold illegally-sourced cannabis last December, said this is an “inflection point” where investors will call into question the depth of corporate governance at some cannabis producers.
 
“Health Canada is sending a message that entrepreneurial creativity is not allowed in a regulated environment,” Robinson said in a phone interview with BNN Bloomberg. “With market caps for companies in the billions of dollars, you have to act like a real business, take a look at the bottom line and not just pursue growth for the sake of it.” 
 
 
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse